Evidence map›Paper›PMID 40411873›Full record

ArticleAngewandte Chemie (International ed. in English)2025

Stereocontrol in Conformationally Stable C(sp

Antoine Domain, Guishun Bai, Juan-Carlos Castillo, Hassane Moussa Abdraman, Stéphane Humbel, Michel Giorgi, Jean-Valère Naubron, Sara Chentouf, Jean Rodriguez, Xiaoze Bao and 1 more

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Stereocontrol in Conformationally Stable C(spAngewandte Chemie (International ed. in English) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Antoine DomainAix Marseille Univ, CNRS, Centrale Med, iSm2, Marseille, France.
Guishun BaiCollege of Pharmaceutical Science & Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou, 310014, P.R. China.
Juan-Carlos CastilloEscuela de Ciencias Químicas, Universidad Pedagógica y Tecnológica de Colombia, Avenida Central del Norte 39-115, Tunja, Colombia.
Hassane Moussa AbdramanAix Marseille Univ, CNRS, Centrale Med, iSm2, Marseille, France.
Stéphane HumbelAix Marseille Univ, CNRS, Centrale Med, iSm2, Marseille, France.
Michel GiorgiAix Marseille Université, CNRS, Centrale Med, FSCM, Spectropole, Marseille, France.
Jean-Valère NaubronAix Marseille Université, CNRS, Centrale Med, FSCM, Spectropole, Marseille, France.
Sara ChentoufAix Marseille Université, CNRS, Centrale Med, FSCM, Spectropole, Marseille, France.
Jean RodriguezAix Marseille Univ, CNRS, Centrale Med, iSm2, Marseille, France.
Xiaoze BaoCollege of Pharmaceutical Science & Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou, 310014, P.R. China.
Damien BonneAix Marseille Univ, CNRS, Centrale Med, iSm2, Marseille, France.

Funding

Agence Nationale pour la Recherche ANR-21-CE07-0036Aix-Marseille UniversitéCentrale Marseille,Centre National de la Recherche ScientifiqueUniversidad Pedagógica y Tecnológica de ColombiaYoung Scientists Fund of the National Natural Science Foundation of China 22302176
6 · The paper itself

Abstract

We report a two-step sequence for the enantioselective construction of a rare family of stable C(sp

Indexed as

Benzofuran atropisomersChloronitroalkenesC(sp2)─C(sp3) atropisomersDihydrobenzofurannulationEnantioselective organocatalysis

Identifiers

PMID40411873
PMCPMC12232878

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.